NIMBEX® RESOURCES

AbbVie offers a variety of informative materials and resources on NIMBEX, including:

NIMBEX ICU BROCHURE

A guide to neuromuscular blockers in the intensive care setting

Discover all the considerations, including dosing, administration, and monitoring of NIMBEX for appropriate patients being treated in the ICU.

>> Click to download

NIMBEX DOSING CARD

Overview of NIMBEX dosing

Explore the individualized dosing of NIMBEX for neuromuscular blockade in inpatient and outpatient procedures.

>> Click to download

NIMBEX AVAILABLE TO ORDER

Ordering information for NIMBEX

All the information your facility needs to place a wholesale or direct order for NIMBEX.

>> Click to download

CLINICAL STUDIES

Access the clinical evidence behind NIMBEX(r) (cisatracurium besylate)

Review a library of reprints that support NIMBEX and other AbbVie anesthesia products.

PMID798277

Prielipp RC, Coursin DB, Scuderi PE, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg. 1995;81(1):3-12

PMID: 7598277

Click to view
PMID11952434

Pühringer FK, Heier T, Dodgson M, et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients. Acta Anaesthesiol Scand. 2002;46(4):364-371

PMID: 11952434

Click to view
PMID20576632

Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105(3):304-309

PMID: 20576632

Click to view
PMID20576632

Arain SR, Kern S, Ficke DJ, Ebert TJ. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand. 2005;49(3):312-315.

PMID: 15752394

Click to view